Better A1C, weight seen with canagliflozin treatment

04/15/2013 | MedWire News (U.K.)

Type 2 diabetes patients who used canagliflozin as an add-on to metformin/sulfonylurea treatment showed better A1C levels and body weight at 52 weeks than those who took sitagliptin, according to a study in Diabetes Care. Researchers also found 47.6% of canagliflozin-treated patients attained an A1C of less than 7%, compared with 35.3% in the sitagliptin group.

View Full Article in:

MedWire News (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC